News | Cardiovascular Business | September 28, 2023

PaceMate Announces Industry Partnership with MedAxiom

PaceMate, a market leading cardiac data management platform, announced today industry partnership with MedAxiom, the cardiovascular community's premier source for organizational performance solutions

September 28, 2023 — PaceMate, a market leading cardiac data management platform, announced today industry partnership with MedAxiom, the cardiovascular community's premier source for organizational performance solutions. 

PaceMate offers comprehensive and flexible cardiac data management software and 24.7.365 clinical service and communications solutions. PaceMate is the market leader in electronic health record interoperability, harmonizing disparate cardiac and EHR data to create workflow solutions in a single, cloud-native environment. 

"We are thrilled to embark on this partnership with PaceMate. Their commitment to innovation and advancing healthcare technology aligns with our vision for the future of cardiology. The insights and experience that they bring will prove to be an asset to the MedAxiom community." said Joe Sasson, PhD, MedAxiom's EVP of Ventures and chief commercial officer. 

PaceMate's user-friendly dashboard helps deliver streamlined workflow solutions for implantable cardiac devices, ambulatory cardiac monitors, heart failure and consumer ECG devices; integrates with all electronic health records (EHRs) and provides seamless connectivity with real-time, bidirectional integrations. PaceMate's solutions also extend to patient prioritization, automatically prioritizing the most vulnerable patients first through customizable algorithms empowered with real-time EHR data integrations and device alerts. 

"We are excited to announce our new partnership with MedAxiom, a renowned leader in cardiovascular healthcare transformation," said Tripp Higgins, CEO and co-founder at PaceMate. "This collaboration reinforces our commitment to advancing cardiac digital healthcare through innovative solutions and strategic partnerships. Together with MedAxiom, we are poised to deliver enhanced value to patients, healthcare providers and the entire cardiovascular community." 

For more information: www.pacemate.com


Related Content

News | Cardiovascular Business

July 29, 2024 — Edwards Lifesciences announced investments that reflect the company’s deep commitment to advancing ...

Home July 29, 2024
Home
News | Cardiovascular Business

July 18, 2024 — Circle Cardiovascular Imaging, a developer of artificial intelligence (AI)-driven cardiovascular imaging ...

Home July 18, 2024
Home
News | Cardiovascular Business

July 15, 2024 — Guidehealth, an artificial intelligence (AI)-enabled healthcare services company, has announced a ...

Home July 15, 2024
Home
News | Cardiovascular Business

July 15, 2024 — Edwards Lifesciences announced it has exercised its option to acquire Innovalve Bio Medical Ltd., an ...

Home July 15, 2024
Home
News | Cardiovascular Business

July 11, 2024 — Medical device company R3 Vascular Inc., developer of novel, best-in-class bioresorbable scaffolds for ...

Home July 11, 2024
Home
News | Cardiovascular Business

July 9, 2024 — Disparities in cardiovascular disease outcomes between urban and rural areas continue to widen, yet ...

Home July 09, 2024
Home
Feature | Cardiovascular Business

The DAIC team wishes you a safe and happy 4th of July!

Home July 04, 2024
Home
News | Cardiovascular Business

July 3, 2024 — Over the past decade, 342 cardiology clinics have been acquired by private equity firms, with over 94% of ...

Home July 03, 2024
Home
Feature | Cardiovascular Business | By Melinda Taschetta-Millane

From FDA approvals to new clinical trials, here is a look at DAIC's top-read content during the month of June: 1 ...

Home July 02, 2024
Home
News | Cardiovascular Business

July 1, 2024 — CVRx, Inc., a commercial-stage medical device company, announced three additions to its senior leadership ...

Home July 01, 2024
Home
Subscribe Now